Literature DB >> 11738466

Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders.

J J Stolker1, E R Heerdink, H G Leufkens, M G Clerkx, W A Nolen.   

Abstract

Prevalence rates of psychotropic drug use in people with intellectual disabilities are high and pharmacotherapy is often attempted with multiple drugs. The presence of disruptive behavior is an important factor associated with the use of psychotropic drugs in this population. We wanted to gain insight into prevalence and determinants of multiple psychotropic drug use among patients with mild intellectual disabilities or borderline intellectual functioning with psychiatric or behavioral disorders. Therefore, data on psychotropics and possible determinants of use were retrospectively collected during 1992-1997 in a specialized closed ward of a Dutch general psychiatric hospital. We defined multiple drug use as concomitant prescription (regular or as needed) of a combination of benzodiazepines/tranquilizers/antipsychotics/anticonvulsants/anti-depressants. Multiple drug use, seen in 48% of the patients, was associated with a long duration of stay, psychosis, aggressive, bizarre, attention-seeking behavior and involuntary measures. We conclude that it is likely that difficulties in the management of socially disruptive behavior are often countered by multiple drug prescription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738466     DOI: 10.1016/s0163-8343(01)00164-5

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  6 in total

1.  Mood and Anxiety Symptoms in Psychiatric Inpatients with Autism Spectrum Disorder and Depression.

Authors:  Lauren Charlot; Curtis K Deutsch; Aranya Albert; Anne Hunt; Daniel F Connor; William J McIlvane
Journal:  J Ment Health Res Intellect Disabil       Date:  2008

Review 2.  Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research.

Authors:  Maire O'Dwyer; Philip McCallion; Mary McCarron; Martin Henman
Journal:  Ther Adv Drug Saf       Date:  2018-06-20

Review 3.  Aggressive behaviour in adults with intellectual disability: defining the role of drug treatment.

Authors:  Patricia Oliver-Africano; Declan Murphy; Peter Tyrer
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

4.  Prescription of psychoactive drugs in patients attended by the SUS at Manhuaçu - MG (Brazil).

Authors:  Daniel P Gonçalves; Ian V Silva; Letícia B Rangel; Lucas C Rezende
Journal:  Pharm Pract (Granada)       Date:  2011-12-12

5.  Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.

Authors:  Máire O'Dwyer; Jure Peklar; Philip McCallion; Mary McCarron; Martin C Henman
Journal:  BMJ Open       Date:  2016-04-04       Impact factor: 2.692

6.  It is time to bring borderline intellectual functioning back into the main fold of classification systems.

Authors:  Jannelien Wieland; Frans G Zitman
Journal:  BJPsych Bull       Date:  2016-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.